Fulcrum Therapeutics (FULC) EBITDA (2018 - 2026)
Fulcrum Therapeutics' EBITDA was -$29.11 million in Q2 2026, compared with -$19.52 million a year earlier.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) EBITDA (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fulcrum Therapeutics' EBITDA was -$94.85 million through Jun 30, 2026; for FY2025, it was -$83.37 million.
- In earlier years, EBITDA was -$20.3 million in FY2024, -$108.46 million in FY2023, -$110.15 million in FY2022 and -$78.54 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBITDA since Q1 2024.
- Per Business Quant data, FULC's EBITDA in the three quarters before Q2 2026 was -$21.85 million (Q1 2026), -$22.34 million (Q4 2025) and -$21.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Fulcrum Therapeutics | 283.78 Mn | 283.78 Mn | - | -29.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.11 Mn |
| Mar 31, 2026 | -21.85 Mn |
| Dec 31, 2025 | -22.34 Mn |
| Sep 30, 2025 | -21.56 Mn |
| Jun 30, 2025 | -19.52 Mn |
| Mar 31, 2025 | -20.00 Mn |
| Dec 31, 2024 | -19.05 Mn |
| Sep 30, 2024 | -24.73 Mn |
| Jun 30, 2024 | 52.89 Mn |
| Mar 31, 2024 | -29.33 Mn |
| Dec 31, 2023 | -27.49 Mn |
| Sep 30, 2023 | -26.94 Mn |
| Jun 30, 2023 | -26.69 Mn |
| Mar 31, 2023 | -27.34 Mn |
| Dec 31, 2022 | -27.38 Mn |
| Sep 30, 2022 | -23.76 Mn |
| Jun 30, 2022 | -33.54 Mn |
| Mar 31, 2022 | -25.46 Mn |
| Dec 31, 2021 | -22.94 Mn |
| Sep 30, 2021 | -20.17 Mn |
API Access
Fulcrum Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();